Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
HB Electrophoresis is a diagnostic test that separates and identifies different types of hemoglobin in the blood to diagnose hemoglobin disorders.
This test is used to diagnose conditions like sickle cell disease and thalassemia, monitor disease progression, and screen for hemoglobin disorders.
No special preparation is needed. You can eat and drink normally, but inform your healthcare provider about any medications or health conditions.
Results are typically available within 2 to 3 days after the test.
The results provide information on the different types of hemoglobin present and their quantities, helping to diagnose and manage hemoglobin disorders and genetic conditions.
CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.
CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.
CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.
Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.
CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.
High CPK-MB levels typically indicate heart muscle damage, such as from a heart attack.
Yes, certain medications can influence CPK-MB levels. It’s important to inform your healthcare provider about all medications you are taking.
No, fasting is not required for the CPK-MB test unless specified by your healthcare provider.
The frequency of testing depends on your health condition and your healthcare provider’s recommendations.
Abnormal CPK-MB levels may indicate heart muscle damage. Further evaluation and treatment will be necessary based on your test results.